EBRO 2017

Overall survival by choice of primary treatment

p = 0.73

Only factor significant on MVA analysis was development of ovarian cancer. (HR 5.0, p = 0.0001)

Pierce et al. BCRT, 2010

Made with FlippingBook Learn more on our blog